Turalio

Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions
Endpoints
Mon, 08/5/19 - 11:32 am
Daiichi Sankyo
FDA
pexidartinib
Turalio
tenosynovial giant cell tumors